Home
Presentations
Events
Image Gallery
Contact Us
About Toshiba

Presentations - Physics - Helical CT Scanning

Dr. Steven Wolff - Carnegie Hill Radiology, New York, USA

Dr. Steven D. Wolff, M.D., Ph.D. is Director of Carnegie Hill Radiology. Dr. Wolff is also Assistant Professor of Clinical Radiology and Medicine at Columbia University and Chief of Cardiac MRI at Lenox Hill Hospital. He was formerly a Senior Clinical Investigator at the National Institutes of Health and Director of Cardiovascular MRI and CT at the Cardiovascular Research Foundation. Dr. Wolff has been listed as one of the Top Doctors in New York by New York Magazine. He is a recognized expert in cardiovascular imaging. Dr. Wolff has been invited to speak at numerous meetings nationally and internationally. He has directed more than 40 courses and workshops, and holds several U.S. patents. Dr. Wolff has served as Trustee for the Society of Cardiovascular Magnetic Resonance. He has served as Deputy Editor for the journal Radiology and has been a member of the editorial board for the Journal of Cardiovascular Magnetic Resonance. He has co-authored more than 40 peer-reviewed manuscripts (see Google Scholar). Dr. Wolff was graduated Summa Cum Laude from Yale College. He received his M.D. and Ph.D. from Duke University. He completed a radiology residency at Johns Hopkins Hospital and is certified in Diagnostic Radiology by the American Board of Radiology.

Keynote Highlights

Dr. Steven D. Wolff, Director of Carnegie Hill Radiology presented many cases including an example of a patient with an abdominal aortic aneurysm comparing scans with Toshiba's Aquilion PRIME (DLP = 364 mGy-cm sc) to the previous system (DLP = 1506 mGy-cm) concluding "You can see the images are of similar quality but the dose was more than 75% less because of our using iterative reconstruction. This has advantages in other areas as well such as coronary CTA where we can achieve low doses, citing another case example, a patient with atypical chest pain where it was possible to rule out coronary artery disease, with the dose from the CTA was only 1.1 mSv."

 

Website, Video Production, Photography: Waxworks Creative